Alcon AG | ALC - Текущие активы





Текущие активы Изменить Дата
AstraZeneca USD 31.45B 3.48B 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Essilor EUR 11.24B 770M 2026-06
Fresenius EUR 12.29B 678M 2026-09
Fresenius Medical Care EUR 7.84B 150.6M 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
GRIFOLS EUR 5.35B 40M 2026-09
Lonza CHF 8B 3.41B 2025-12
Merck EUR 15.14B 1.37B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Philips EUR 10.51B 1.18B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
Smith & Nephew USD 4.39B 240M 2026-06
Sonova Holding CHF 1.91B 466.3M 2025-06
UCB EUR 6.05B 733M 2025-12